Cabazitaxel Teva

Country: European Union

Language: Bulgarian

Source: EMA (European Medicines Agency)

Buy It Now

Active ingredient:

кабазитаксел

Available from:

Teva B.V.

ATC code:

L01CD04

INN (International Name):

cabazitaxel

Therapeutic group:

Антинеопластични средства

Therapeutic area:

Простатни неоплазми

Therapeutic indications:

Лечение на рак на простатата .

Authorization status:

Отказана

Documents in other languages

Public Assessment Report Public Assessment Report Spanish 24-07-2019
Public Assessment Report Public Assessment Report Czech 24-07-2019
Public Assessment Report Public Assessment Report Danish 24-07-2019
Public Assessment Report Public Assessment Report German 24-07-2019
Public Assessment Report Public Assessment Report Estonian 24-07-2019
Public Assessment Report Public Assessment Report Greek 24-07-2019
Public Assessment Report Public Assessment Report English 24-07-2019
Public Assessment Report Public Assessment Report French 24-07-2019
Public Assessment Report Public Assessment Report Italian 24-07-2019
Public Assessment Report Public Assessment Report Latvian 24-07-2019
Public Assessment Report Public Assessment Report Lithuanian 24-07-2019
Public Assessment Report Public Assessment Report Hungarian 24-07-2019
Public Assessment Report Public Assessment Report Maltese 24-07-2019
Public Assessment Report Public Assessment Report Dutch 24-07-2019
Public Assessment Report Public Assessment Report Polish 24-07-2019
Public Assessment Report Public Assessment Report Portuguese 24-07-2019
Public Assessment Report Public Assessment Report Romanian 24-07-2019
Public Assessment Report Public Assessment Report Slovak 24-07-2019
Public Assessment Report Public Assessment Report Slovenian 24-07-2019
Public Assessment Report Public Assessment Report Finnish 24-07-2019
Public Assessment Report Public Assessment Report Swedish 24-07-2019
Public Assessment Report Public Assessment Report Croatian 24-07-2019

Search alerts related to this product